Yoshinori Sugino
Keio University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoshinori Sugino.
International Journal of Clinical Oncology | 2008
Toshirou Nishida; Seiichi Hirota; Akio Yanagisawa; Yoshinori Sugino; Manabu Minami; Yoshitaka Yamamura; Yoshihide Otani; Yasuhiro Shimada; Fumiaki Takahashi; Tetsuro Kubota
Diagnostic and treatment strategies for gastrointestinal stromal tumors (GISTs) have evolved greatly since the introduction of molecularly targeted therapies. Although several clinical practice guidelines are extant, such as those published by the National Comprehensive Cancer Network and the European Society of Medical Oncology, it is not clear as to whether these are appropriate for clinical practice in Japan. Therefore, clinical practice guidelines for the optimal diagnosis and treatment of GIST tailored for the Japanese situation have often been requested. For this reason, the Japanese Clinical Practice Guideline for GIST was proposed by the GIST Guideline Subcommittee, with the official approval of the Clinical Practice Guidelines Committee for Cancer of the Japan Society of Clinical Oncology (JSCO), and was published after assessment by the Guideline Evaluation Committee of JSCO. The GIST Guideline Subcommittee consists of members from JSCO, the Japanese Gastric Cancer Association (JGCA), and the Japanese Study Group on GIST, with the official approval of these organizations. The GIST Guideline Subcommittee is not influenced by any other organizations or third parties. Revision of the guideline may be done periodically, with the approval of the GIST Guideline Subcommittee, either every 3 years or when important new evidence that might alter the optimal diagnosis and treatment of GIST emerges. Here we present the English version of the Japanese Clinical Practice Guideline for GIST prepared by the GIST Guideline Subcommittee.
World Journal of Surgery | 2006
Yoshiro Saikawa; Yoshihide Otani; Yuko Kitagawa; Masashi Yoshida; Norihito Wada; Tetsuro Kubota; Koichiro Kumai; Yoshinori Sugino; Makio Mukai; Kaori Kameyama; Atsushi Kubo; Masaki Kitajima
IntroductionIntraoperative detection of sentinel nodes (SNs) has been used clinically to predict regional lymph node (LN) metastasis in patients with breast cancer and malignant melanoma. Intraoperative lymphatic mapping and SN biopsy can potentially be combined with minimally invasive surgery. However, few reports have demonstrated the validity of SN biopsy during laparoscopic gastrectomy. The aim of this study was to investigate the feasibility and accuracy of laparoscopic lymphatic mapping in predicting LN status in patients with gastric cancer.MethodsA total of 35 patients with gastric cancer diagnosed preoperatively as T1, N0 were enrolled. Endoscopic injection of technetium-99m-radiolabeled tin colloid was completed 16 hours before surgery, and radioactive SNs were identified with a gamma probe intraoperatively. Isosulfan blue dye was injected endoscopically during the operation. Laparoscopy-assisted gastrectomy with LN dissection was performed. All resected LNs were evaluated by routine pathology examination.ResultsSNs were detected in 33 (94.3%) of 35 patients. The mean number of SNs was 3.9, and the diagnostic accuracy according to SN status was 97.0% (32/33), as one patient with a false-negative result was observed. The patient with the false-negative specimen was finally diagnosed as having advanced gastric cancer with invasion into the proper muscular layer and severe lymphatic vessel invasion, causing destruction of normal lymphatic flow by the tumor.ConclusionsRadio-guided SN mapping during laparoscopic gastrectomy is an accurate diagnostic tool for detecting lymph node metastasis in patients with early-stage gastric cancer. Validation of this method requires further studies on technical issues, including indications, tracers, methods of lymph node retrieval, and diagnostic modalities of metastasis.
Journal of Gastroenterology | 2008
Haruhiko Ogata; Koichiro Kumai; Hiroyuki Imaeda; Koichi Aiura; Tadakazu Hisamatsu; Susumu Okamoto; Yasushi Iwao; Yoshinori Sugino; Masaki Kitajima; Toshifumi Hibi
BackgroundA new capsule endoscope has been developed by Olympus Medical Systems. The visualization and usefulness of its real-time image viewer for gastric transit abnormality were evaluated by using this new device.MethodsThirty-seven consecutive patients were enrolled. In cases of gastric transit abnormality (gastric transit > 60 min, detected by the real-time viewer), intramuscular metoclopramide (10 mg) was administered. Diagnostic yield and gastric and small bowel transit times in ten patients receiving (group A) and 27 not receiving (group B) metoclopramide were analyzed.ResultsMedian gastric transit time was longer in group A than in group B (110 vs. 24 min; P < 0.0001). Conversely, median small bowel transit time was shorter in group A than in group B (270 vs. 347 min; P < 0.05). Further, small bowel transit was complete in 9/10 patients (90%) in group A, and in 23/27 patients (85%) in group B, but the difference was not significant. Overall diagnostic yield was 78% (29/37 patients), and there was no significant difference in the ratio of abnormal findings documented between group A (8/10, 80%) and group B (21/27, 78%) patients.ConclusionsThis new technology allowed clear image interpretation, and the real-time viewer was useful for detecting gastric transit abnormalities and determining a need for metoclopramide administration in patients undergoing capsule endoscopy.
Gastric Cancer | 2000
Tomohisa Egawa; Tetsuro Kubota; Yoshihide Otani; Naoto Kurihara; Sadanori Abe; Masaru Kimata; Joh Tokuyama; Norihito Wada; Kazuhiro Suganuma; Yuusuke Kuwano; Koichiro Kumai; Yoshinori Sugino; Makio Mukai; Masaki Kitajima
Cronkhite-Canada syndrome is generally accepted to be a benign disorder, with 374 reported cases to the present. Worldwide, there have been 18 previously reported cases of Cronkhite-Canada syndrome associated with gastric cancer. In this report we describe a case of a 52-year-old man with the clinical features of Cronkhite-Canada syndrome combined with gastric cancer. Although the gastric tumor was located at the antrum of the stomach, we performed a total gastrectomy because of the edematous swelling and high risk of malignancy in the remnant stomach. As Cronkhite-Canada syndrome may be a premalignant condition for gastric cancer, as well as for colorectal cancer, we suggest periodic examination of the stomach, colon, and rectum for patients with Cronkhite-Canada syndrome.
Journal of Gastroenterology and Hepatology | 2008
Eisuke Iwasaki; Hidekazu Suzuki; Yoshinori Sugino; Tsutomu Iida; Toshihiro Nishizawa; Tatsuhiro Masaoka; Hiroshi Hosoda; Kenji Kangawa; Toshifumi Hibi
Background: Body mass index (BMI) and obesity are reportedly associated with symptoms of gastroesophageal reflux disease (GERD). The present study was designed to investigate the effect of metabolic disorders including obesity on the levels of functional gastroesophageal reflux by videoesophagography.
Surgery Today | 2004
Naoko Hashiguchi; Tetsuro Kubota; Yoshihide Otani; Masashi Yoshida; Shingo Maeda; Joh Tokuyama; Norihito Wada; Kazuhiro Suganuma; Yusuke Kuwano; Koichiro Kumai; Yoshinori Sugino; Makio Mukai; Hankei Shin; Masaki Kitajima
Ischemic heart disorders are often treated by coronary artery bypass grafting (CABG) using the right gastroepiploic artery (RGEA). We report the case of a 57-year-old man with a history of CABG using the RGEA, who underwent D2 radical total gastrectomy followed by Roux-en-Y anastomosis, with successful dissection of the #6 lymph nodes, while preserving the RGEA. The patient had a 9-month history of gastric cancer, during which time the Maruyama Vaccine (Specific Substance Maruyama, or SSM) was given as alternative therapy. This case report serves to demonstrate that radical gastrectomy can be safely performed after CABG using the RGEA, and that gastric cancer will progress in spite of SSM therapy.
PLOS ONE | 2015
Juntaro Matsuzaki; Hidekazu Suzuki; Masao Kobayakawa; John M. Inadomi; Michiyo Takayama; Kanako Makino; Yasushi Iwao; Yoshinori Sugino; Takanori Kanai
Background Central obesity has been suggested as a risk factor for gastroesophageal reflux disease. The aim of this study was to evaluate the association of visceral fat area and other lifestyle factors with reflux esophagitis or Barrett’s esophagus in Japanese population. Methods Individuals who received thorough medical examinations including the measurement of visceral fat area by abdominal computed tomography were enrolled. Factors associated with the presence of reflux esophagitis, the severity of reflux esophagitis, or the presence of Barrett’s esophagus were determined using multivariable logistic regression models. Results A total of 2608 individuals were eligible for the analyses. Visceral fat area was associated with the presence of reflux esophagitis both in men (odds ratio, 1.21 per 50 cm2; 95% confident interval, 1.01 to 1.46) and women (odds ratio, 2.31 per 50 cm2; 95% confident interval, 1.57 to 3.40). Current smoking and serum levels of triglyceride were also associated with the presence of reflux esophagitis in men. However, significant association between visceral fat area and the severity of reflux esophagitis or the presence of Barrett’s esophagus was not shown. In men, excessive alcohol consumption on a drinking day, but not the frequency of alcohol drinking, was associated with both the severity of reflux esophagitis (odds ratio, 2.13; 95% confident interval, 1.03 to 4.41) and the presence of Barrett’s esophagus (odds ratio, 1.71; 95% confident interval, 1.14 to 2.56). Conclusion Visceral fat area was independently associated with the presence of reflux esophagitis, but not with the presence of Barrett’s esophagus. On the other hand, quantity of alcohol consumption could play a role in the development of severe reflux esophagitis and Barrett’s esophagus in Japanese population.
Angiology | 1985
Hitoshi Asakura; Toshikazu Takagi; Kensuke Kobayashi; Sadakazu Aiso; Toshifumi Hibi; Yoshinori Sugino; Kyoichi Hiramatsu; Tatsuo Teramoto; Masaharu Tsuchiya
A 16 year old man with complaints of abdominal pain, diarrhea, high fever and loss of body weight was made a diagnosis of Crohns disease. During the administration, he had intestinal obstruction and several episodes of massive intestinal bleeding. Selective angiography of the superior mesenteric artery demonstrated the bleeding site in the ileum. Microangiography of the surgical specimens revealed abrupt interruptions of arteriae rectae in the submucosa indicating the bleeding site from the diseased intestine.
Neurogastroenterology and Motility | 2010
Juntaro Matsuzaki; Hidekazu Suzuki; Eisuke Iwasaki; Hirokazu Yokoyama; Yoshinori Sugino; Toshifumi Hibi
Background Metabolic syndrome and obesity are known risk factors for gastro‐esophageal reflux disease (GERD), especially for erosive esophagitis. Although non‐erosive reflux disease (NERD) is probably associated with obesity or other metabolic syndrome, there is little direct evidence to support this assertion.
Journal of Gastroenterology | 1996
Hiroshi Serizawa; Toshifumi Hibi; Tazuko Ohishi; Noriaki Watanabe; Yoshiki Hamada; Masahiko Watanabe; Masahiro Ohgami; Yoshinori Sugino; Shigeru Kuramochi; Hiromasa Ishii
We describe a 22-year-old man with Crohns ileocolitis accompanied by intestinal stenosis and ileovesical fistula in whom laparoscopically-assisted surgery was successfully performed after thorough nutritional therapy. Laparoscopic procedures are characterized by minimal access and minimal invasion, features which can contribute to the early recovery of patients who undergo surgery. It is suggested that laparoscopic (or laparoscopically-assisted) surgery after strict nutritional therapy can be effective in the treatment of patients with Crohns disease who have intestinal complications.